Differential KrasV12 protein levels control a switch regulating lung cancer cell morphology and motility.

Together these data highlight previously unappreciated roles for the quantitative effects of expression level variation of oncogenic signaling molecules in conferring fundamental alterations in cell function regulation required for cancer progression.